NK Cells Market Report

Global NK Cells Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Jun 08, 2022
  • PAGES：228
  • REPORT CODE：GMM850252
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • NK Cells market report explains the definition, types, applications, major countries, and major players of the NK Cells market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Sorrento Therapeutics Inc (USA)

    • Affimed NV (Netherlands)

    • Chipscreen Biosciences (China)

    • Altor BioScience Corporation (USA)

    • NKT Therapeutics (USA)

    • Innate Pharma SA (France)

    • Bristol-Myers Squibb (USA)

    • NantKwest Inc (USA)

    • Takeda Pharmaceutical (Japan)

    By Type:

    • Mogamulizumab

    • Lorvotuzumab Mertansine

    • Others

    By End-User:

    • Cancer

    • Cardiovascular Diseases

    • Others

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global NK Cells Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 NK Cells Outlook to 2028- Original Forecasts

    • 2.2 NK Cells Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term NK Cells Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global NK Cells Market- Recent Developments

    • 6.1 NK Cells Market News and Developments

    • 6.2 NK Cells Market Deals Landscape

    7 NK Cells Raw Materials and Cost Structure Analysis

    • 7.1 NK Cells Key Raw Materials

    • 7.2 NK Cells Price Trend of Key Raw Materials

    • 7.3 NK Cells Key Suppliers of Raw Materials

    • 7.4 NK Cells Market Concentration Rate of Raw Materials

    • 7.5 NK Cells Cost Structure Analysis

      • 7.5.1 NK Cells Raw Materials Analysis

      • 7.5.2 NK Cells Labor Cost Analysis

      • 7.5.3 NK Cells Manufacturing Expenses Analysis

    8 Global NK Cells Import and Export Analysis (Top 10 Countries)

    • 8.1 Global NK Cells Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global NK Cells Export by Region (Top 10 Countries) (2017-2028)

    9 Global NK Cells Market Outlook by Types and Applications to 2022

    • 9.1 Global NK Cells Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Mogamulizumab Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Lorvotuzumab Mertansine Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global NK Cells Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Cardiovascular Diseases Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Others Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise NK Cells Market Analysis and Outlook till 2022

    • 10.1 Global NK Cells Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States NK Cells Consumption (2017-2022)

      • 10.2.2 Canada NK Cells Consumption (2017-2022)

      • 10.2.3 Mexico NK Cells Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany NK Cells Consumption (2017-2022)

      • 10.3.2 UK NK Cells Consumption (2017-2022)

      • 10.3.3 Spain NK Cells Consumption (2017-2022)

      • 10.3.4 Belgium NK Cells Consumption (2017-2022)

      • 10.3.5 France NK Cells Consumption (2017-2022)

      • 10.3.6 Italy NK Cells Consumption (2017-2022)

      • 10.3.7 Denmark NK Cells Consumption (2017-2022)

      • 10.3.8 Finland NK Cells Consumption (2017-2022)

      • 10.3.9 Norway NK Cells Consumption (2017-2022)

      • 10.3.10 Sweden NK Cells Consumption (2017-2022)

      • 10.3.11 Poland NK Cells Consumption (2017-2022)

      • 10.3.12 Russia NK Cells Consumption (2017-2022)

      • 10.3.13 Turkey NK Cells Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China NK Cells Consumption (2017-2022)

      • 10.4.2 Japan NK Cells Consumption (2017-2022)

      • 10.4.3 India NK Cells Consumption (2017-2022)

      • 10.4.4 South Korea NK Cells Consumption (2017-2022)

      • 10.4.5 Pakistan NK Cells Consumption (2017-2022)

      • 10.4.6 Bangladesh NK Cells Consumption (2017-2022)

      • 10.4.7 Indonesia NK Cells Consumption (2017-2022)

      • 10.4.8 Thailand NK Cells Consumption (2017-2022)

      • 10.4.9 Singapore NK Cells Consumption (2017-2022)

      • 10.4.10 Malaysia NK Cells Consumption (2017-2022)

      • 10.4.11 Philippines NK Cells Consumption (2017-2022)

      • 10.4.12 Vietnam NK Cells Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil NK Cells Consumption (2017-2022)

      • 10.5.2 Colombia NK Cells Consumption (2017-2022)

      • 10.5.3 Chile NK Cells Consumption (2017-2022)

      • 10.5.4 Argentina NK Cells Consumption (2017-2022)

      • 10.5.5 Venezuela NK Cells Consumption (2017-2022)

      • 10.5.6 Peru NK Cells Consumption (2017-2022)

      • 10.5.7 Puerto Rico NK Cells Consumption (2017-2022)

      • 10.5.8 Ecuador NK Cells Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain NK Cells Consumption (2017-2022)

      • 10.6.2 Kuwait NK Cells Consumption (2017-2022)

      • 10.6.3 Oman NK Cells Consumption (2017-2022)

      • 10.6.4 Qatar NK Cells Consumption (2017-2022)

      • 10.6.5 Saudi Arabia NK Cells Consumption (2017-2022)

      • 10.6.6 United Arab Emirates NK Cells Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria NK Cells Consumption (2017-2022)

      • 10.7.2 South Africa NK Cells Consumption (2017-2022)

      • 10.7.3 Egypt NK Cells Consumption (2017-2022)

      • 10.7.4 Algeria NK Cells Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia NK Cells Consumption (2017-2022)

      • 10.8.2 New Zealand NK Cells Consumption (2017-2022)

    11 Global NK Cells Competitive Analysis

    • 11.1 Sorrento Therapeutics Inc (USA)

      • 11.1.1 Sorrento Therapeutics Inc (USA) Company Details

      • 11.1.2 Sorrento Therapeutics Inc (USA) NK Cells Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Sorrento Therapeutics Inc (USA) NK Cells Main Business and Markets Served

      • 11.1.4 Sorrento Therapeutics Inc (USA) NK Cells Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Affimed NV (Netherlands)

      • 11.2.1 Affimed NV (Netherlands) Company Details

      • 11.2.2 Affimed NV (Netherlands) NK Cells Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Affimed NV (Netherlands) NK Cells Main Business and Markets Served

      • 11.2.4 Affimed NV (Netherlands) NK Cells Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Chipscreen Biosciences (China)

      • 11.3.1 Chipscreen Biosciences (China) Company Details

      • 11.3.2 Chipscreen Biosciences (China) NK Cells Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Chipscreen Biosciences (China) NK Cells Main Business and Markets Served

      • 11.3.4 Chipscreen Biosciences (China) NK Cells Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Altor BioScience Corporation (USA)

      • 11.4.1 Altor BioScience Corporation (USA) Company Details

      • 11.4.2 Altor BioScience Corporation (USA) NK Cells Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Altor BioScience Corporation (USA) NK Cells Main Business and Markets Served

      • 11.4.4 Altor BioScience Corporation (USA) NK Cells Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 NKT Therapeutics (USA)

      • 11.5.1 NKT Therapeutics (USA) Company Details

      • 11.5.2 NKT Therapeutics (USA) NK Cells Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 NKT Therapeutics (USA) NK Cells Main Business and Markets Served

      • 11.5.4 NKT Therapeutics (USA) NK Cells Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Innate Pharma SA (France)

      • 11.6.1 Innate Pharma SA (France) Company Details

      • 11.6.2 Innate Pharma SA (France) NK Cells Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Innate Pharma SA (France) NK Cells Main Business and Markets Served

      • 11.6.4 Innate Pharma SA (France) NK Cells Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Bristol-Myers Squibb (USA)

      • 11.7.1 Bristol-Myers Squibb (USA) Company Details

      • 11.7.2 Bristol-Myers Squibb (USA) NK Cells Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Bristol-Myers Squibb (USA) NK Cells Main Business and Markets Served

      • 11.7.4 Bristol-Myers Squibb (USA) NK Cells Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 NantKwest Inc (USA)

      • 11.8.1 NantKwest Inc (USA) Company Details

      • 11.8.2 NantKwest Inc (USA) NK Cells Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 NantKwest Inc (USA) NK Cells Main Business and Markets Served

      • 11.8.4 NantKwest Inc (USA) NK Cells Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Takeda Pharmaceutical (Japan)

      • 11.9.1 Takeda Pharmaceutical (Japan) Company Details

      • 11.9.2 Takeda Pharmaceutical (Japan) NK Cells Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Takeda Pharmaceutical (Japan) NK Cells Main Business and Markets Served

      • 11.9.4 Takeda Pharmaceutical (Japan) NK Cells Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    12 Global NK Cells Market Outlook by Types and Applications to 2028

    • 12.1 Global NK Cells Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Mogamulizumab Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Lorvotuzumab Mertansine Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global NK Cells Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Cardiovascular Diseases Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise NK Cells Market Analysis and Outlook to 2028

    • 13.1 Global NK Cells Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States NK Cells Consumption Forecast (2022-2028)

      • 13.2.2 Canada NK Cells Consumption Forecast (2022-2028)

      • 13.2.3 Mexico NK Cells Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany NK Cells Consumption Forecast (2022-2028)

      • 13.3.2 UK NK Cells Consumption Forecast (2022-2028)

      • 13.3.3 Spain NK Cells Consumption Forecast (2022-2028)

      • 13.3.4 Belgium NK Cells Consumption Forecast (2022-2028)

      • 13.3.5 France NK Cells Consumption Forecast (2022-2028)

      • 13.3.6 Italy NK Cells Consumption Forecast (2022-2028)

      • 13.3.7 Denmark NK Cells Consumption Forecast (2022-2028)

      • 13.3.8 Finland NK Cells Consumption Forecast (2022-2028)

      • 13.3.9 Norway NK Cells Consumption Forecast (2022-2028)

      • 13.3.10 Sweden NK Cells Consumption Forecast (2022-2028)

      • 13.3.11 Poland NK Cells Consumption Forecast (2022-2028)

      • 13.3.12 Russia NK Cells Consumption Forecast (2022-2028)

      • 13.3.13 Turkey NK Cells Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China NK Cells Consumption Forecast (2022-2028)

      • 13.4.2 Japan NK Cells Consumption Forecast (2022-2028)

      • 13.4.3 India NK Cells Consumption Forecast (2022-2028)

      • 13.4.4 South Korea NK Cells Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan NK Cells Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh NK Cells Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia NK Cells Consumption Forecast (2022-2028)

      • 13.4.8 Thailand NK Cells Consumption Forecast (2022-2028)

      • 13.4.9 Singapore NK Cells Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia NK Cells Consumption Forecast (2022-2028)

      • 13.4.11 Philippines NK Cells Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam NK Cells Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil NK Cells Consumption Forecast (2022-2028)

      • 13.5.2 Colombia NK Cells Consumption Forecast (2022-2028)

      • 13.5.3 Chile NK Cells Consumption Forecast (2022-2028)

      • 13.5.4 Argentina NK Cells Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela NK Cells Consumption Forecast (2022-2028)

      • 13.5.6 Peru NK Cells Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico NK Cells Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador NK Cells Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain NK Cells Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait NK Cells Consumption Forecast (2022-2028)

      • 13.6.3 Oman NK Cells Consumption Forecast (2022-2028)

      • 13.6.4 Qatar NK Cells Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia NK Cells Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates NK Cells Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria NK Cells Consumption Forecast (2022-2028)

      • 13.7.2 South Africa NK Cells Consumption Forecast (2022-2028)

      • 13.7.3 Egypt NK Cells Consumption Forecast (2022-2028)

      • 13.7.4 Algeria NK Cells Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia NK Cells Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand NK Cells Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of NK Cells

    • Figure of NK Cells Picture

    • Table Global NK Cells Import by Region (Top 10 Countries) (2017-2028)

    • Table Global NK Cells Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Mogamulizumab Consumption and Growth Rate (2017-2022)

    • Figure Global Lorvotuzumab Mertansine Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Cardiovascular Diseases Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global NK Cells Consumption by Country (2017-2022)

    • Table North America NK Cells Consumption by Country (2017-2022)

    • Figure United States NK Cells Consumption and Growth Rate (2017-2022)

    • Figure Canada NK Cells Consumption and Growth Rate (2017-2022)

    • Figure Mexico NK Cells Consumption and Growth Rate (2017-2022)

    • Table Europe NK Cells Consumption by Country (2017-2022)

    • Figure Germany NK Cells Consumption and Growth Rate (2017-2022)

    • Figure UK NK Cells Consumption and Growth Rate (2017-2022)

    • Figure Spain NK Cells Consumption and Growth Rate (2017-2022)

    • Figure Belgium NK Cells Consumption and Growth Rate (2017-2022)

    • Figure France NK Cells Consumption and Growth Rate (2017-2022)

    • Figure Italy NK Cells Consumption and Growth Rate (2017-2022)

    • Figure Denmark NK Cells Consumption and Growth Rate (2017-2022)

    • Figure Finland NK Cells Consumption and Growth Rate (2017-2022)

    • Figure Norway NK Cells Consumption and Growth Rate (2017-2022)

    • Figure Sweden NK Cells Consumption and Growth Rate (2017-2022)

    • Figure Poland NK Cells Consumption and Growth Rate (2017-2022)

    • Figure Russia NK Cells Consumption and Growth Rate (2017-2022)

    • Figure Turkey NK Cells Consumption and Growth Rate (2017-2022)

    • Table APAC NK Cells Consumption by Country (2017-2022)

    • Figure China NK Cells Consumption and Growth Rate (2017-2022)

    • Figure Japan NK Cells Consumption and Growth Rate (2017-2022)

    • Figure India NK Cells Consumption and Growth Rate (2017-2022)

    • Figure South Korea NK Cells Consumption and Growth Rate (2017-2022)

    • Figure Pakistan NK Cells Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh NK Cells Consumption and Growth Rate (2017-2022)

    • Figure Indonesia NK Cells Consumption and Growth Rate (2017-2022)

    • Figure Thailand NK Cells Consumption and Growth Rate (2017-2022)

    • Figure Singapore NK Cells Consumption and Growth Rate (2017-2022)

    • Figure Malaysia NK Cells Consumption and Growth Rate (2017-2022)

    • Figure Philippines NK Cells Consumption and Growth Rate (2017-2022)

    • Figure Vietnam NK Cells Consumption and Growth Rate (2017-2022)

    • Table South America NK Cells Consumption by Country (2017-2022)

    • Figure Brazil NK Cells Consumption and Growth Rate (2017-2022)

    • Figure Colombia NK Cells Consumption and Growth Rate (2017-2022)

    • Figure Chile NK Cells Consumption and Growth Rate (2017-2022)

    • Figure Argentina NK Cells Consumption and Growth Rate (2017-2022)

    • Figure Venezuela NK Cells Consumption and Growth Rate (2017-2022)

    • Figure Peru NK Cells Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico NK Cells Consumption and Growth Rate (2017-2022)

    • Figure Ecuador NK Cells Consumption and Growth Rate (2017-2022)

    • Table GCC NK Cells Consumption by Country (2017-2022)

    • Figure Bahrain NK Cells Consumption and Growth Rate (2017-2022)

    • Figure Kuwait NK Cells Consumption and Growth Rate (2017-2022)

    • Figure Oman NK Cells Consumption and Growth Rate (2017-2022)

    • Figure Qatar NK Cells Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia NK Cells Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates NK Cells Consumption and Growth Rate (2017-2022)

    • Table Africa NK Cells Consumption by Country (2017-2022)

    • Figure Nigeria NK Cells Consumption and Growth Rate (2017-2022)

    • Figure South Africa NK Cells Consumption and Growth Rate (2017-2022)

    • Figure Egypt NK Cells Consumption and Growth Rate (2017-2022)

    • Figure Algeria NK Cells Consumption and Growth Rate (2017-2022)

    • Table Oceania NK Cells Consumption by Country (2017-2022)

    • Figure Australia NK Cells Consumption and Growth Rate (2017-2022)

    • Figure New Zealand NK Cells Consumption and Growth Rate (2017-2022)

    • Table Sorrento Therapeutics Inc (USA) Company Details

    • Table Sorrento Therapeutics Inc (USA) NK Cells Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sorrento Therapeutics Inc (USA) NK Cells Main Business and Markets Served

    • Table Sorrento Therapeutics Inc (USA) NK Cells Product Portfolio

    • Table Affimed NV (Netherlands) Company Details

    • Table Affimed NV (Netherlands) NK Cells Sales, Price, Value and Gross Profit (2017-2022)

    • Table Affimed NV (Netherlands) NK Cells Main Business and Markets Served

    • Table Affimed NV (Netherlands) NK Cells Product Portfolio

    • Table Chipscreen Biosciences (China) Company Details

    • Table Chipscreen Biosciences (China) NK Cells Sales, Price, Value and Gross Profit (2017-2022)

    • Table Chipscreen Biosciences (China) NK Cells Main Business and Markets Served

    • Table Chipscreen Biosciences (China) NK Cells Product Portfolio

    • Table Altor BioScience Corporation (USA) Company Details

    • Table Altor BioScience Corporation (USA) NK Cells Sales, Price, Value and Gross Profit (2017-2022)

    • Table Altor BioScience Corporation (USA) NK Cells Main Business and Markets Served

    • Table Altor BioScience Corporation (USA) NK Cells Product Portfolio

    • Table NKT Therapeutics (USA) Company Details

    • Table NKT Therapeutics (USA) NK Cells Sales, Price, Value and Gross Profit (2017-2022)

    • Table NKT Therapeutics (USA) NK Cells Main Business and Markets Served

    • Table NKT Therapeutics (USA) NK Cells Product Portfolio

    • Table Innate Pharma SA (France) Company Details

    • Table Innate Pharma SA (France) NK Cells Sales, Price, Value and Gross Profit (2017-2022)

    • Table Innate Pharma SA (France) NK Cells Main Business and Markets Served

    • Table Innate Pharma SA (France) NK Cells Product Portfolio

    • Table Bristol-Myers Squibb (USA) Company Details

    • Table Bristol-Myers Squibb (USA) NK Cells Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bristol-Myers Squibb (USA) NK Cells Main Business and Markets Served

    • Table Bristol-Myers Squibb (USA) NK Cells Product Portfolio

    • Table NantKwest Inc (USA) Company Details

    • Table NantKwest Inc (USA) NK Cells Sales, Price, Value and Gross Profit (2017-2022)

    • Table NantKwest Inc (USA) NK Cells Main Business and Markets Served

    • Table NantKwest Inc (USA) NK Cells Product Portfolio

    • Table Takeda Pharmaceutical (Japan) Company Details

    • Table Takeda Pharmaceutical (Japan) NK Cells Sales, Price, Value and Gross Profit (2017-2022)

    • Table Takeda Pharmaceutical (Japan) NK Cells Main Business and Markets Served

    • Table Takeda Pharmaceutical (Japan) NK Cells Product Portfolio

    • Figure Global Mogamulizumab Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Lorvotuzumab Mertansine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cardiovascular Diseases Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global NK Cells Consumption Forecast by Country (2022-2028)

    • Table North America NK Cells Consumption Forecast by Country (2022-2028)

    • Figure United States NK Cells Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada NK Cells Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico NK Cells Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe NK Cells Consumption Forecast by Country (2022-2028)

    • Figure Germany NK Cells Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK NK Cells Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain NK Cells Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium NK Cells Consumption Forecast and Growth Rate (2022-2028)

    • Figure France NK Cells Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy NK Cells Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark NK Cells Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland NK Cells Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway NK Cells Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden NK Cells Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland NK Cells Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia NK Cells Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey NK Cells Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC NK Cells Consumption Forecast by Country (2022-2028)

    • Figure China NK Cells Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan NK Cells Consumption Forecast and Growth Rate (2022-2028)

    • Figure India NK Cells Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea NK Cells Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan NK Cells Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh NK Cells Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia NK Cells Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand NK Cells Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore NK Cells Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia NK Cells Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines NK Cells Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam NK Cells Consumption Forecast and Growth Rate (2022-2028)

    • Table South America NK Cells Consumption Forecast by Country (2022-2028)

    • Figure Brazil NK Cells Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia NK Cells Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile NK Cells Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina NK Cells Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela NK Cells Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru NK Cells Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico NK Cells Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador NK Cells Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC NK Cells Consumption Forecast by Country (2022-2028)

    • Figure Bahrain NK Cells Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait NK Cells Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman NK Cells Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar NK Cells Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia NK Cells Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates NK Cells Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa NK Cells Consumption Forecast by Country (2022-2028)

    • Figure Nigeria NK Cells Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa NK Cells Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt NK Cells Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria NK Cells Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania NK Cells Consumption Forecast by Country (2022-2028)

    • Figure Australia NK Cells Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand NK Cells Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US